Baird Financial Group’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Baird Financial Group's BCAT Position: Q1 2026 in Review
Baird Financial Group increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 11% in Q1 2026, buying an estimated $129K and bringing the position to 88,675 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1199.
Baird Financial Group first reported a position in BCAT in Q2 2022 and has held it in 16 quarters since. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Baird Financial Group held 88,675 shares of BlackRock Capital Allocation Term Trust worth $1.25M as of Q1 2026.
- Baird Financial Group bought 8,783 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $129K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1199 holding.
- Baird Financial Group first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and has held it in 16 quarters since.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.